| scholarly article | Q13442814 |
| P50 | author | John Anthony Hardy | Q6237755 |
| Jennifer S Yokoyama | Q87688044 | ||
| Jana Vandrovcova | Q28946165 | ||
| Ole A. Andreassen | Q31229142 | ||
| Sebastian Guelfi | Q38633537 | ||
| Livia Bernardi | Q44809420 | ||
| Celeste M Karch | Q56449209 | ||
| Bruce L. Miller | Q56825815 | ||
| Raffaele Ferrari | Q56909556 | ||
| Anders M. Dale | Q57693390 | ||
| Andrew J Schork | Q64091574 | ||
| Parastoo Momeni | Q66729652 | ||
| Gil D Rabinovici | Q87489631 | ||
| P2093 | author name string | Gerard D Schellenberg | |
| Yunpeng Wang | |||
| Leo P Sugrue | |||
| Christopher P Hess | |||
| James B Brewer | |||
| Luke W Bonham | |||
| Rahul S Desikan | |||
| William P Dillon | |||
| Chun C Fan | |||
| Aree Witeolar | |||
| International FTD-Genomics Consortium (IFGC), | |||
| International Genomics of Alzheimer's Project (IGAP), | |||
| International Parkinson's Disease Genomics Consortium (IPDGC), | |||
| P2860 | cites work | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 |
| Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies | Q24606055 | ||
| TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT | Q26851112 | ||
| Parkinsonian syndrome in familial frontotemporal dementia | Q26852893 | ||
| Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Q27686837 | ||
| Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 | ||
| Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
| Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease | Q28943440 | ||
| METAL: fast and efficient meta-analysis of genomewide association scans | Q29547217 | ||
| Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease | Q29614900 | ||
| Phagocytic clearance in neurodegeneration | Q30427542 | ||
| Frontotemporal dementia and its subtypes: a genome-wide association study | Q33955007 | ||
| Distinguishing Alzheimer's disease from other major forms of dementia | Q34225873 | ||
| Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease | Q34471227 | ||
| Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus | Q35963497 | ||
| The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. | Q36142564 | ||
| An exploratory analysis on gene-environment interactions for Parkinson disease | Q36165052 | ||
| HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk | Q36318142 | ||
| Evolutionary dynamism of the primate LRRC37 gene family | Q36490025 | ||
| Frontotemporal dementia to Alzheimer's disease. | Q36922125 | ||
| Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease | Q36999150 | ||
| Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia | Q37100964 | ||
| Genetic pleiotropy in complex traits and diseases: implications for genomic medicine | Q37111321 | ||
| Invited article: the Alzheimer disease-frontotemporal lobar degeneration spectrum | Q37288221 | ||
| Apolipoprotein E in Alzheimer's disease and other neurological disorders | Q37846932 | ||
| Phenotypic signatures of genetic frontotemporal dementia | Q37944092 | ||
| Tau pathology and neurodegeneration | Q38107632 | ||
| Apolipoprotein E polymorphisms in frontotemporal lobar degeneration: a meta-analysis. | Q38108035 | ||
| Genetic insights into common pathways and complex relationships among immune-mediated diseases | Q38126785 | ||
| Theory of mind in behavioural-variant frontotemporal dementia and Alzheimer's disease: a meta-analysis | Q38321051 | ||
| Frontotemporal dementia: insights into the biological underpinnings of disease through gene co-expression network analysis | Q38611043 | ||
| HLA-DQA2 and HLA-DQB2 genes are specifically expressed in human Langerhans cells and encode a new HLA class II molecule | Q39381555 | ||
| Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors | Q39965012 | ||
| Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing. | Q41436485 | ||
| Association between Parkinson's disease and the HLA-DRB1 locus | Q47374004 | ||
| The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. | Q47831429 | ||
| Tau propagation, different tau phenotypes, and prion-like properties of tau. | Q48707817 | ||
| Updated TDP-43 in Alzheimer's disease staging scheme | Q48949710 | ||
| Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. | Q51788691 | ||
| Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. | Q51922561 | ||
| The spectrum of behavioral changes in Alzheimer's disease. | Q53210662 | ||
| Frontotemporal dementia. | Q53268278 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| Parkinson's disease | Q11085 | ||
| frontotemporal dementia | Q18592 | ||
| dementia | Q83030 | ||
| P304 | page(s) | 152-164 | |
| P577 | publication date | 2016-11-29 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases | |
| P478 | volume | 88 |
| Q64764750 | Q64764750 |
| Q64443593 | A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity |
| Q64119486 | Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer's Disease |
| Q64073366 | ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology |
| Q91268052 | Biomedical informatics applications for precision management of neurodegenerative diseases |
| Q52317581 | CXCR4 involvement in neurodegenerative diseases. |
| Q90101893 | Discovery of shared genomic loci using the conditional false discovery rate approach |
| Q93137333 | Epigenetic signatures of methylated DNA cytosine in Alzheimer's disease |
| Q50102071 | Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease |
| Q55091667 | GWAS on family history of Alzheimer's disease. |
| Q92881950 | Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative |
| Q90124366 | Genetic modifiers and non-Mendelian aspects of CMT |
| Q92477950 | Genome Wide Association Study and Next Generation Sequencing: A Glimmer of Light Toward New Possible Horizons in Frontotemporal Dementia Research |
| Q90574117 | Genome-wide Association Analysis of Parkinson's Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci |
| Q99614808 | Identifying Risk Genes and Interpreting Pathogenesis for Parkinson's Disease by a Multiomics Analysis |
| Q47218394 | Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies |
| Q50107952 | Novel Loci Associated With Attention-Deficit/Hyperactivity Disorder Are Revealed by Leveraging Polygenic Overlap With Educational Attainment |
| Q47563700 | Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains. |
| Q90286842 | PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment |
| Q60923524 | Parkinson's disease and Alzheimer's disease: a Mendelian randomization study |
| Q59808730 | Perspectives on the Genomics of HSP Beyond Mendelian Inheritance |
| Q53397478 | Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease. |
| Q57060450 | Protein network analysis reveals selectively vulnerable regions and biological processes in FTD |
| Q55462837 | Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease. |
| Q53513139 | Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum. |
| Q58699032 | The Luxembourg Parkinson's Study: A Comprehensive Approach for Stratification and Early Diagnosis |
| Q92570889 | The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes |
| Q52644606 | The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades. |
| Q89697688 | The genetic architecture of dementia with Lewy bodies is shaping up |
| Q60054668 | Uncoupling protein 4 () gene variability in neurodegenerative disorders: further evidence of association in Frontotemporal dementia |
| Q93051633 | Whole Exome Sequencing Study of Parkinson Disease and Related Endophenotypes in the Italian Population |
Search more.